medigraphic.com
ISSN 2007-6800 (Print)

2013, Number 2

<< Back Next >>

Rev Mex Traspl 2013; 2 (2)

The start of a liver transplant program at the Hospital General de Mexico

Córdova J, Rossano-García A, García-Covarrubias L, Cícero-Lebrija A, Luque-Hernández A, Fernández-Ángel D, Hinojosa-Heredia H, Diliz-Pérez HS

Language: Spanish
References: 20
Page: 58-63
PDF size: 210.29 Kb.


ABSTRACT

Liver transplantation is the gold standard of the treatment of patients with terminal liver disease. This treatment offers an excellent quality of life to these patients and increases their survival. The main indications of liver transplantation worldwide are cirrhosis caused by chronic viral hepatitis C and alcohol. In Mexico, we perform approximately 80 to 100 liver transplantation per year; been insufficient for the number of patients that are in attending list and the number of patients that die from this disease in our country. In the Mexico’s General Hospital, eight liver transplantations have been performed from July 2011 to May 2012; two patients died (acute respiratory distress syndrome and primary non function) and six patients are alive and have an excellent quality of live. The main early complications were: infections (pneumonia and sepsis) and the late ones were mainly metabolic. Liver transplantation offers an excelent survival and quality of live to the patients with chronic liver disease.


REFERENCES

  1. Murray KF, Carithers RL Jr. AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation. Hepatology. 2005: 1-26.

  2. Francoz C, Belghiti J, Durand F. Indications of liver transplantation in patients with complications of cirrhosis. Best Pract Res Clin Gastroenterol. 2007; 21 (1): 175-90.

  3. Burra P, Freeman R. Trends in liver transplantation. J of Hepatol. 2012: S101-S111.

  4. Kotlyar DS, Burke A, Campbell MS, Weinrieb RM. A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease. Am J Gastroenterol. 2008; 103 (3): 734-43.

  5. Kemmer N, Neff G. Recipient-based approach to tailoring immunosuppression in liver transplantation. Transplant Proc. 2010; 42 (5): 1731-7.

  6. Olson JC, Wendon JA, Kramer DJ et al. Intensive care of the patient with cirrhosis. Hepatology. 2011: 1864-1872.

  7. Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care. 2011; 17 (2): 165-9.

  8. Kamath PS, Kim WR. Advanced liver disease study group. The model for end-stage liver disease (MELD). Hepatology. 2007; 45 (3): 797-805.

  9. Torphy J. Liver Transplantation. JAMA. 2012: 320.

  10. Berg CL, Merion RM, Shearon TH et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology. 2011: 1313-1321.

  11. Ozhathil DK, Li YF, Smith JK et al. Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl. 2011: 1191-1199.

  12. Samuel D, Colombo M, El-Serag H, Sobesky R, Heaton N. Toward Optimizing the Indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transplant. 2011; 2: S6-S13.

  13. Lai JC, Feng S, Roberts JP, Terrault NA. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant. 2011; 11 (2): 296-302.

  14. Umgelter A, Lange K, Kornberg A, Büchler P, Friess H, Schmid RM. Orthotopic liver transplantation in critically Ill cirrhotic patients with multiorgan failure: A single-center experience. Transplantation Proceedings. 2011; 43: 3762-3768.

  15. Alqahtani S. Update in liver transplantation. Curr Op. 2012: 230-238.

  16. Trotter J, Osgood L. MELD scores of liver transplant recipients according to size of waiting list impact of organ allocation and patient outcomes. JAMA. 2004; 15 (291): 1871-1874.

  17. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008: 2371-2378.

  18. Fink MA, Angus PW, Gow PJ et al. Liver transplant recipient selection: MELD versus Clinical judgment. Liver Transplantation. 2005; 11 (6): 621-626.

  19. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deseased donor liver transplantation as a function of candidate disease severity and donor quality. Am J of Transp. 2008; 8 (2): 419-425.

  20. Das V, Boelle PY, Galbois A et al. Cirrhotic patients in the medical intensive care unit: Early prognosis and long-term survival. Crit Care Med. 2010; 38 (11): 2108-2116.




2020     |     www.medigraphic.com